Will The Supply Shortage Weigh On Eli Lilly’s Q2?

Eli Lilly stock (NYSE: LLY) will report its Q2 results on Thursday, August 8. The pharmaceutical giant is expected to garner $10 billion in sales and $2.70 in adjusted earnings per share, per the consensus estimates. All eyes will be on Eli Lilly’s diabetes drug – Mou

admin